Differential fadE28 expression associated with phenotypic virulence of Mycobacterium tuberculosis

Microbial Pathogenesis

Volumn 45, Issue 1, 2008, Pages 12-17

  Lam, T H J ^a   Yuen, K Y ^a   Ho, P L ^a   Wong, K C ^a   Leong, W M ^a   Law, H K W ^a   Weng, X H ^b   Zhang, W H ^b   Chen, S ^b   Yam, W C ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b FUDAN UNIVERSITY   (China)

Author keywords

Differential gene expression; fadE28; Hypervirulent strain; Mycobacterium tuberculosis

Indexed keywords

FATTY ACID;

ACR GENE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CONTROLLED STUDY; EX VIVO STUDY; FADE28 GENE; FATTY ACID OXIDATION; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MCE1A GENE; MYCOBACTERIUM TUBERCULOSIS; MYMA GENE; NONHUMAN; PHAGOSOME; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RRS GENE; RV3723 GENE; SIGA GENE; SUGC GENE; UPREGULATION;

ACYL-COA DEHYDROGENASE; BACTERIAL PROTEINS; CELLS, CULTURED; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MACROPHAGES; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; PHYLOGENY; TUBERCULOSIS, MENINGEAL; UP-REGULATION; VIRULENCE;

MYCOBACTERIUM TUBERCULOSIS;

EID: 44649197096     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2008.01.006     Document Type: Article

References (42)

1. World Health Organisation. Tuberculosis fact sheet number 104; revised March 2006.
2. Marris E. Extreme TB strain threatens HIV victims worldwide. Nature 443 (2006) 131
3. Suter E. The multiplication of tubercle bacilli within normal phagocytosis in tissue culture. J Exp Med 96 (1952) 137-150
4. Morse W.C., Weiser O.L., Kuhns D.M., Fusillo M., Dail M.C., and Evans J.R. Study of the virulence of isoniazid-resistant tubercle bacilli in guinea pigs and mice: a preliminary report. Am Rev Tuberc 69 (1954) 464-468
5. Li Z., Kelley C., Collins F., Rouse D., and Morris S. Expression of katG in Mycobacterium tuberculosis is associated with its growth and persistence in mice and guinea pigs. J Infect Dis 177 (1998) 1030-1035
6. Arruda S., Bomfim G., Knights R., Huima-Byron T., and Riley L.W. Cloning of an M. tuberculosis DNA fragment associated with entry and survival inside cells. Science 261 (1993) 1454-1457
7. Chitale S., Ehrt S., Kawamura I., Fujimura T., Shimono N., Anand N., et al. Recombinant Mycobacterium tuberculosis protein associated with mammalian cell entry. Cell Microbiol 3 (2001) 247-254
8. Lu S., Tager L.A., Chitale S., and Riley L.W. A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis. Anal Biochem 353 (2006) 7-14
9. McKinney J.D., Honer zu Bentrup K., Munoz-Elias E.J., Miczak A., Chen B., Chan W.T., et al. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 406 (2000) 735-738
10. Reed M.B., Domenech P., Manca C., Su H., Barczak A.K., Kreiswirth B.N., et al. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431 (2004) 84-87
11. Fisher M.A., Plikaytis B.B., and Shinnick T.M. Microarray analysis of the Mycobacterium tuberculosis transcriptional response to the acidic conditions found in phagosomes. J Bacteriol 184 (2002) 4025-4032
12. Singh A., Jain S., Gupta S., Das T., and Tyagi A.K. mymA operon of Mycobacterium tuberculosis: its regulation and importance in the cell envelope. FEMS Microbiol Lett 227 (2003) 53-63
13. Singh A., Gupta R., Vishwakarma R.A., Narayanan P.R., Paramasivan C.N., Ramanathan V.D., et al. Requirement of the mymA operon for appropriate cell wall ultrastructure and persistence of Mycobacterium tuberculosis in the spleens of guinea pigs. J Bacteriol 187 (2005) 4173-4186
14. Schnappinger D., Ehrt S., Voskuil M.I., Liu Y., Mangan J.A., Monahan I.M., et al. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment. J Exp Med 198 (2003) 693-704
15. Yuan Y., Crane D.D., and Barry III C.E. Stationary phase-associated protein expression in Mycobacterium tuberculosis: function of the mycobacterial α-crystallin homolog. J Bacteriol 178 (1996) 4484-4492
16. Stewart J.N., Rivera H.N., Karls R., Quinn F.D., Roman J., and Rivera-Marrero C.A. Increased pathology in lungs of mice after infection with an α-crystallin mutant of Mycobacterium tuberculosis: changes in cathepsin proteases and certain cytokines. Microbiology 152 (2006) 233-244
17. Manganelli R., Provvedi R., Rodrigue S., Beaucher J., Graudreau L., and Smith L. Sigma factors and global gene regulation in Mycobacterium tuberculosis. J Bacteriol 186 (2004) 895-902
18. Collins D.M., Kawakami R.P., de Lisle G.W., Pascopella L., Bloom B.R., and Jacobs Jr. W.R. Mutation of the principal σ factor causes loss of virulence in a strain of the Mycobacterium tuberculosis complex. Proc Natl Acad Sci U S A 92 (1995) 8036-8040
19. Wu S., Howard S.T., Lakey D.L., Kipnis A., Samten B., Safi H., et al. The principal sigma factor sigA mediates enhanced growth of Mycobacterium tuberculosis in vivo. Mol Microbiol 51 (2004) 1551-1562
20. Rengarajan J., Bloom B.R., and Rubin E.J. Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages. Proc Natl Acad Sci U S A 102 (2005) 8327-8332
21. Sassetti C.M., and Rubin E.J. Genetic requirements for mycobacterial survival during infection. Proc Natl Acad Sci U S A 100 (2003) 12989-12994
22. Muñoz-Elías E.J., and McKinney J.D. Carbon metabolism of intracellular bacteria. Cell Microbiol 8 (2006) 10-22
23. Braibant M., Gilot P., and Content J. The ATP binding cassette (ABC) transport systems of Mycobacterium tuberculosis. FEMS Microbiol Rev 24 (2000) 449-467
24. Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C., Harris D., et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393 (1998) 537-544
25. Zhang M., Gong J., Yang Z., Samten B., Cave M.D., and Barnes P.F. Enhanced capacity of a widespread strain of Mycobacterium tuberculosis to grow in human macrophages. J Infect Dis 179 (1999) 1213-1217
26. Li Q., Whalen C.C., Albert J.M., Larkin R., Zukowski L., Cave M.D., et al. Differences in rate and variability of intracellular growth of a panel of Mycobacterium tuberculosis clinical isolates within a human monocyte model. Infect Immun 70 (2002) 6489-6493
27. Wong K.C., Leong W.M., Law H.K., Ip K.F., Lam J.T., Yuen K.Y., et al. Molecular characterization of clinical isolates of Mycobacterium tuberculosis and their association with phenotypic virulence in human macrophages. Clin Vaccine Immunol 14 (2007) 1279-1284
28. López B., Aguilar D., Orozco H., Burger M., Espitia C., Ritacco V., et al. A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin Exp Immunol 133 (2003) 30-37
29. Dormans J., Burger M., Aguilar D., Hernandez-Pando R., Kremer K., Roholl P., et al. Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model. Clin Exp Immunol 137 (2004) 460-468
30. Pethe K., Swenson D.L., Alonso S., Anderson J., Wang C., and Russell D.G. Isolation of Mycobacterium tuberculosis mutants defective in the arrest of phagosome maturation. Proc Natl Acad Sci U S A 101 (2004) 13642-13647
31. Bloch H., and Segal W. Biochemical differentiation of Mycobacterium tuberculosis grown in vivo and in vitro. J Bacteriol 72 (1956) 132-141
32. Bynyan P.J., and Greenbaum A.L. The effect of treatment of rats with pituitary growth hormone on the activities of some enzymes involved in fatty acid degradation and synthesis. Biochem J 96 (1965) 432-438
33. Ghisla S., and Thorpe C. Acyl-CoA dehydrogenases. A mechanistic overview. Eur J Biochem 271 (2004) 494-508
34. Rao V, Gao F, Chen B, Jacobs WR, Glickman MS. Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis-induced inflammation and virulence. J Clin Invest;116:1660-67.
35. Fleischmann R.D., Alland D., Eisen J.A., Carpenter L., White O., Peterson J., et al. Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol 184 (2002) 5479-5490
36. Mahadevan U., and Padmanaban G. Cloning and expression of an acyl-CoA dehydrogenase from Mycobacterium tuberculosis. Biochem Biophys Res Commun 244 (1998) 893-897
37. Cheung C.Y., Poon L.L., Lau A.S., Luk W., Lau Y.L., Shortridge K.F., et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?. Lancet 360 (2002) 1831-1837
38. Monahan I.M., Mangan J.A., and Butcher P.D. Extraction of RNA from intracellular Mycobacterium tuberculosis. In: Parish T., and Stoker N.G. (Eds). Mycobacterium tuberculosis protocols (2001), Humana Press, Totowa 31-42
39. Shi L., Jung Y.J., Tyagi S., Gennaro M.L., and North R.J. Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence. Proc Natl Acad Sci U S A 100 (2003) 241-246
40. Eleaume H., and Jabbouri S. Comparison of two standardisation methods in real-time quantitative RT-PCR to follow Staphylococcus aureus gene expression during in vitro growth. J Microbiol Methods 59 (2004) 363-370
41. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29 (2001) e45
42. Novagen. pET-15b vector. [online] (1999). http://www.merckbiosciences.com/docs/docs/PROT/TB045.pdf